Spotlight Asset Group’s Pulse Biosciences PLSE Stock Holding History

Spotlight Asset Group’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$451K	Sell	40,290 -31,800	-44%	-$300K	0.31%	49
2024 Q1	$628K	Hold	72,090	–	–	0.45%	39
2023 Q4	$291K	Hold	72,090	–	–	0.26%	50
2023 Q3	$291K	Buy	72,090 +5,665	+9%	+$35.2K	0.26%	50
2023 Q2	$478K	Hold	66,425	–	–	0.43%	35
2023 Q1	$147K	Buy	+66,425	New	+$200K	0.15%	70
2022 Q3	$147K	Buy	+66,425	New	+$108K	0.15%	70
2021 Q3	$571K	Hold	26,425	–	–	0.28%	61
2021 Q2	$433K	Buy	26,425 +5,000	+23%	+$95.2K	0.17%	81
2021 Q1	$507K	Buy	21,425 +159	+0.7%	+$4.75K	0.19%	75
2020 Q4	$507K	Buy	21,266 +5,000	+31%	+$79.5K	0.19%	73
2020 Q3	$192K	Hold	16,266	–	–	0.08%	134
2020 Q2	$170K	Buy	+16,266	New	+$146K	0.07%	131

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Spotlight Asset Group's PLSE Position: Q2 2024 in Review

Spotlight Asset Group reduced its Pulse Biosciences (PLSE) stake by 44% in Q2 2024, selling an estimated $300K and leaving 40,290 shares worth $451K. The position accounts for 0.31% of the portfolio, ranked #49.

Spotlight Asset Group first reported a position in PLSE in Q2 2020 and has held it in 13 quarters since. The position peaked at $628K in Q1 2024. 57 funds tracked by Wall St. Rank hold PLSE as of Q2 2024.

Spotlight Asset Group held 40,290 shares of Pulse Biosciences worth $451K as of Q2 2024.
Spotlight Asset Group sold 31,800 Pulse Biosciences shares in Q2 2024, an estimated $300K.
Pulse Biosciences made up 0.31% of Spotlight Asset Group's portfolio in Q2 2024, its #49 holding.
Spotlight Asset Group first reported a position in Pulse Biosciences in Q2 2020 and has held it in 13 quarters since.
Spotlight Asset Group's Pulse Biosciences position peaked at $628K in Q1 2024.
57 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.